Publicaciones en las que colabora con Juan Antonio Bueren Calabuig (8)

2016

  1. Stepwise Simulation of 3,5-Dihydro-5-methylidene-4H-imidazol-4-one (MIO) Biogenesis in Histidine Ammonia-lyase

    Biochemistry, Vol. 55, Núm. 41, pp. 5854-5864

2012

  1. Erratum: Rationale for the opposite stereochemistry of the major monoadducts and interstrand crosslinks formed by mitomycin C and its decarbamoylated analogue at CpG steps in DNA and the effect of cytosine modification on reactivity (Organic and Biomolecular Chemistry (2012) 10 (1543-1552) DOI: 10.1039/C1OB06675G))

    Organic and Biomolecular Chemistry

  2. Rationale for the opposite stereochemistry of the major monoadducts and interstrand crosslinks formed by mitomycin C and its decarbamoylated analogue at CpG steps in DNA and the effect of cytosine modification on reactivity

    Organic and Biomolecular Chemistry, Vol. 10, Núm. 8, pp. 1543-1552

2011

  1. Mechanistic insight into the catalytic activity of ββα-metallonucleases from computer simulations: Vibrio vulnificus periplasmic nuclease as a test case

    ChemBioChem, Vol. 12, Núm. 17, pp. 2615-2622

  2. Temperature-induced melting of double-stranded DNA in the absence and presence of covalently bonded antitumour drugs: Insight from molecular dynamics simulations

    Nucleic Acids Research, Vol. 39, Núm. 18, pp. 8248-8257

  3. XPF-dependent DNA breaks and RNA polymerase II arrest induced by antitumor DNA interstrand crosslinking-mimetic alkaloids

    Chemistry and Biology, Vol. 18, Núm. 8, pp. 988-999

2010

  1. PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity

    British Journal of Pharmacology, Vol. 161, Núm. 5, pp. 1099-1110

2009

  1. Molecular pharmacology and antitumor activity of Zalypsis® in several human cancer cell lines

    Biochemical Pharmacology, Vol. 78, Núm. 2, pp. 162-170